Jiangsu Aidea Pharmaceutical Co., Ltd has marked its debut on the Nasdaq-style STAR Market of the Shanghai Stock Exchange (SSE) after raising 839 million yuan ($120 million) in its IPO, according to a company filing with the bourse on Monday.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com